Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer-Reference-Cited by-同舟云学术

Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer

Published:2022-10-19 Issue:1 Volume:13 Page:1140-1152
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Moench Romana¹²,Gasser Martin³,Nawalaniec Karol¹,Grimmig Tanja²,Ajay Amrendra K.¹,de Souza Larissa Camila Ribeiro¹,Cao Minghua¹,Luo Yueming¹⁴,Hoegger Petra⁵,Ribas Carmen M.⁶,Ribas-Filho Jurandir M.⁶,Malafaia Osvaldo⁶,Lissner Reinhard²,Hsiao Li-Li¹⁷,Waaga-Gasser Ana Maria¹²⁷

Affiliation:

1. Renal Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA

2. Department of Surgery I, Molecular Oncology and Immunology, University of Wuerzburg, Wuerzburg 97080, Bavaria, Germany

3. Department of Surgery I, University of Wuerzburg, Wuerzburg 97080, Bavaria, Germany

4. Shenzhen Traditional Chinese Medicine Hospital, Shenzhen 518033, Guangdong Province, China

5. Institute for Pharmacy and Food Chemistry, University of Wuerzburg, Wuerzburg 97074, Bavaria, Germany

6. Mackenzie Evangelical Faculty of Paraná, Curitiba 80730-000, Parana, Brazil

7. Co-senior investigators

Publisher

Impact Journals, LLC

Subject

Oncology

Reference43 articles.

1. Cancer statistics, 2019;Jemal;CA Cancer J Clin,2019

2. [S3-guideline conference "Colorectal Cancer" 2004];Riemann;Dtsch Med Wochenschr,2005

3. Colorectal carcinoma: the management of polyps, (neo)adjuvant therapy, and the treatment of metastases;Reinacher-Schick;Dtsch Arztebl Int,2009

4. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Rogers;N Engl J Med,2004

5. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200;Benson;J Clin Oncol,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitoring imatinib decreasing pericyte coverage and HIF-1α level in a colorectal cancer model by an ultrahigh-field multiparametric MRI approach;Journal of Translational Medicine;2024-07-31

2. The Role of TAMs in the Regulation of Tumor Cell Resistance to Chemotherapy;Critical Reviews™ in Oncogenesis;2024

3. The Genomic Landscape of Colorectal Cancer in the Saudi Arabian Population Using a Comprehensive Genomic Panel;Diagnostics;2023-09-19